subset analysis [General Sta­tis­tics]

posted by sasikumar – Tamilnadu, India, 2009-06-15 15:27 (6224 d 12:37 ago) – Posting: # 3855
Views: 4,781

Dear ElMaestro and HS,

Thanks for your reply.

❝ ❝ 1½: It is unclear why you would go for lower power when the subjects are in trial anyway, …


❝ Budget for bioanalyses?


Yes, since I am working in CRO, I hope that it is absolutely cost constraint of sponsor for bio-analytical. I have plan to mention the model like below for drug 'y',

log y=sequence+subject(sequence)+treatment+period+group+error
Fixed effects: sequence, treatment, period, group
Random effects: subject (sequence)

Regards,
Sasikumar

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
356 visitors (0 registered, 356 guests [including 16 identified bots]).
Forum time: 04:04 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5